| Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome M Tartaglia, LA Pennacchio, C Zhao, KK Yadav, V Fodale, A Sarkozy, ... Nature genetics 39 (1), 75-79, 2007 | 641 | 2007 |
| An orthosteric inhibitor of the Ras-Sos interaction A Patgiri, KK Yadav, PS Arora, D Bar-Sagi Nature chemical biology 7 (9), 585-587, 2011 | 347 | 2011 |
| exRNA atlas analysis reveals distinct extracellular RNA cargo types and their carriers present across human biofluids OD Murillo, W Thistlethwaite, J Rozowsky, SL Subramanian, R Lucero, ... Cell 177 (2), 463-477. e15, 2019 | 261 | 2019 |
| Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death H Hieronymus, R Murali, A Tin, K Yadav, W Abida, H Moller, D Berney, ... Elife 7, e37294, 2018 | 254 | 2018 |
| Integrated nanoscale deterministic lateral displacement arrays for separation of extracellular vesicles from clinically-relevant volumes of biological samples JT Smith, BH Wunsch, N Dogra, ME Ahsen, K Lee, KK Yadav, R Weil, ... Lab on a Chip 18 (24), 3913-3925, 2018 | 151 | 2018 |
| The use of biomarkers in prostate cancer screening and treatment AV Alford, JM Brito, KK Yadav, SS Yadav, AK Tewari, J Renzulli Reviews in urology 19 (4), 221, 2017 | 109 | 2017 |
| Intratumor heterogeneity in prostate cancer SS Yadav, JA Stockert, V Hackert, KK Yadav, AK Tewari Urologic Oncology: Seminars and Original Investigations 36 (8), 349-360, 2018 | 90 | 2018 |
| Radiomics features measured with multiparametric magnetic resonance imaging predict prostate cancer aggressiveness SJ Hectors, M Cherny, KK Yadav, AT Beksaç, H Thulasidass, S Lewis, ... The Journal of urology 202 (3), 498-505, 2019 | 89 | 2019 |
| Allosteric gating of Son of sevenless activity by the histone domain KK Yadav, D Bar-Sagi Proceedings of the National Academy of Sciences 107 (8), 3436-3440, 2010 | 62 | 2010 |
| Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences W Rayford, AT Beksac, J Alger, M Alshalalfa, M Ahmed, I Khan, ... Communications biology 4 (1), 670, 2021 | 59 | 2021 |
| One-way membrane trafficking of SOS in receptor-triggered Ras activation SM Christensen, HL Tu, JE Jun, S Alvarez, MG Triplet, JS Iwig, KK Yadav, ... Nature structural & molecular biology 23 (9), 838-846, 2016 | 59 | 2016 |
| Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment SS Yadav, J Li, HJ Lavery, KK Yadav, AK Tewari Urologic Oncology: Seminars and Original Investigations 33 (6), 267. e1-267. e13, 2015 | 56 | 2015 |
| Inflammation and prostate cancer AK Tewari, JA Stockert, SS Yadav, KK Yadav, I Khan Cell & Molecular Biology of Prostate Cancer: Updates, Insights and New …, 2018 | 42 | 2018 |
| Breakthroughs and applications of organ-on-a-chip technology MC Koyilot, P Natarajan, CR Hunt, S Sivarajkumar, R Roy, S Joglekar, ... Cells 11 (11), 1828, 2022 | 37 | 2022 |
| Predictive value of pseudouridine in prostate cancer JA Stockert, A Gupta, B Herzog, SS Yadav, AK Tewari, KK Yadav American journal of clinical and experimental urology 7 (4), 262, 2019 | 35 | 2019 |
| Induction of neuroendocrine differentiation in prostate cancer cells by dovitinib (TKI-258) and its therapeutic implications SS Yadav, J Li, JA Stockert, B Herzog, J O'Connor, L Garzon-Manco, ... Translational oncology 10 (3), 357-366, 2017 | 34 | 2017 |
| Multiparametric magnetic resonance imaging features identify aggressive prostate cancer at the phenotypic and transcriptomic level AT Beksac, S Cumarasamy, U Falagario, P Xu, M Takhar, M Alshalalfa, ... The Journal of Urology 200 (6), 1241-1249, 2018 | 27 | 2018 |
| Pseudouridine as a novel biomarker in prostate cancer JA Stockert, R Weil, KK Yadav, N Kyprianou, AK Tewari Urologic Oncology: Seminars and Original Investigations 39 (1), 63-71, 2021 | 26 | 2021 |
| Combination effect of therapies targeting the PI3K-and AR-signaling pathways in prostate cancer SS Yadav, J Li, JA Stockert, J O'Connor, B Herzog, C Elaiho, MD Galsky, ... Oncotarget 7 (46), 76181, 2016 | 24 | 2016 |
| Analysis of real-world data to investigate the impact of race and ethnicity on response to programmed cell death-1 and programmed cell death-ligand 1 inhibitors in advanced non … KL Ayers, T Mullaney, X Zhou, JJ Liu, K Lee, M Ma, S Jones, L Li, ... The Oncologist 26 (7), e1226-e1239, 2021 | 22 | 2021 |
Ashutosh K Tewari, MDChairman, Department of Urology, Icahn School of Medicine at Mount Sinai, NY, USAVerified email at mountsinai.org
